Heterodimeric antibodies that bind CD3 and PSMA
US10227410B2 · kind B2 · utility
29Cited by
122References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2016 |
| Grant date | Mar 12, 2019 |
| Priority date | — |
| Expiry date | Dec 7, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to heterodimeric antibodies that bind CD3 and PSMA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.